In vivo and in vitro studies using IGF-1R antibodies, small molecule inhibitors, and antisense technology have shown that IGF-1R is functionally essential for tumor cell growth and proliferation in most if not all forms of cancer [23, 25–28]. The gene discussed is IGF1R; the disease is cancer.